Adaptilens

Boston, United States

Adaptilens is a developer of an accommodating intraocular lens.

$17.5M raised

Apr 2024

Series A

Top Investors

Pillar VCPerceptive AdvisorsMassChallengeAccanto Partners380 Cap

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Adaptilens raised?

Adaptilens has raised $17.5M in total funding. The most recent round was Series A. The last funding was announced in April 2024.

Who are Adaptilens's investors?

Adaptilens's investors include Pillar VC, Perceptive Advisors, MassChallenge, Accanto Partners, 380 Cap.

Where is Adaptilens headquartered?

Adaptilens is headquartered in Boston, United States.

What does Adaptilens do?

Adaptilens is a developer of an accommodating intraocular lens.

What stage is Adaptilens at?

Adaptilens is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 29, 2024.

MLA

"Adaptilens — Funding & Investors." VCBacked, April 29, 2024, https://www.vcbacked.co/company/adaptilens. Accessed June 4, 2026.

APA

VCBacked. (2024). Adaptilens — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/adaptilens

Wikipedia (cite web)

{{cite web |title=Adaptilens — Funding & Investors |url=https://www.vcbacked.co/company/adaptilens |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 29, 2024.